Dynavax Technologies Stock Total Debt
| DVAX Stock | USD 11.72 0.04 0.34% |
Dynavax Technologies fundamentals help investors to digest information that contributes to Dynavax Technologies' financial success or failures. It also enables traders to predict the movement of Dynavax Stock. The fundamental analysis module provides a way to measure Dynavax Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dynavax Technologies stock.
Total Debt To Capitalization is likely to rise to 0.31 in 2024. Dynavax | Total Debt |
Dynavax Technologies Company Total Debt Analysis
Dynavax Technologies' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Dynavax Technologies Total Debt | 256.91 M |
Most of Dynavax Technologies' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dynavax Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Dynavax Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for Dynavax Technologies is extremely important. It helps to project a fair market value of Dynavax Stock properly, considering its historical fundamentals such as Total Debt. Since Dynavax Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dynavax Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dynavax Technologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Dynavax Total Debt Historical Pattern
Today, most investors in Dynavax Technologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Dynavax Technologies' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Dynavax Technologies total debt as a starting point in their analysis.
Dynavax Technologies Total Debt |
| Timeline |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Dynavax Net Debt
Net Debt |
|
Based on the latest financial disclosure, Dynavax Technologies has a Total Debt of 256.91 M. This is 90.66% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 95.17% higher than that of the company.
Dynavax Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dynavax Technologies' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics of similar companies.Dynavax Technologies is currently under evaluation in total debt category among related companies.
Dynavax Technologies Institutional Holders
Institutional Holdings refers to the ownership stake in Dynavax Technologies that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Dynavax Technologies' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Dynavax Technologies' value.| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.5 M | Blair William & Co | 2023-12-31 | 2.4 M | Renaissance Technologies Corp | 2023-12-31 | 1.9 M | Rock Springs Capital Management Lp | 2023-12-31 | 1.7 M | Driehaus Capital Management Llc | 2023-12-31 | 1.6 M | Kynam Capital Management, Lp | 2023-12-31 | 1.5 M | Northern Trust Corp | 2023-12-31 | 1.4 M | Fisher Asset Management, Llc | 2023-12-31 | 1.4 M | Woodline Partners Lp | 2023-12-31 | 1.3 M | Blackrock Inc | 2023-12-31 | 23.4 M | Federated Hermes Inc | 2023-12-31 | 11.4 M |
Dynavax Fundamentals
| Return On Equity | -0.0106 | ||||
| Return On Asset | -0.0192 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 1.04 B | ||||
| Shares Outstanding | 130.86 M | ||||
| Shares Owned By Insiders | 0.31 % | ||||
| Shares Owned By Institutions | 97.97 % | ||||
| Number Of Shares Shorted | 18.54 M | ||||
| Price To Earning | 6.95 X | ||||
| Price To Book | 2.49 X | ||||
| Price To Sales | 6.67 X | ||||
| Revenue | 232.28 M | ||||
| Gross Profit | 448.22 M | ||||
| EBITDA | 20.98 M | ||||
| Net Income | (6.39 M) | ||||
| Cash And Equivalents | 518.17 M | ||||
| Cash Per Share | 4.10 X | ||||
| Total Debt | 256.91 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 2.77 X | ||||
| Book Value Per Share | 4.80 X | ||||
| Cash Flow From Operations | 100.56 M | ||||
| Short Ratio | 10.08 X | ||||
| Earnings Per Share | (0.05) X | ||||
| Target Price | 25.75 | ||||
| Number Of Employees | 408 | ||||
| Beta | 1.28 | ||||
| Market Capitalization | 1.53 B | ||||
| Total Asset | 997.1 M | ||||
| Retained Earnings | (930.58 M) | ||||
| Working Capital | 796.92 M | ||||
| Current Asset | 199.95 M | ||||
| Current Liabilities | 28.79 M | ||||
| Net Asset | 997.1 M |
About Dynavax Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dynavax Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Dynavax Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Dynavax Stock
| 0.84 | EVOK | Evoke Pharma | PairCorr |
Moving against Dynavax Stock
| 0.65 | JAGX | Jaguar Animal Health Financial Report 20th of May 2024 | PairCorr |
| 0.6 | ELYM | Eliem Therapeutics Trending | PairCorr |
| 0.48 | OGN | Organon | PairCorr |
| 0.45 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.
The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Dynavax Technologies Piotroski F Score and Dynavax Technologies Altman Z Score analysis. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Dynavax Stock analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.05) | Revenue Per Share 1.804 | Quarterly Revenue Growth (0.70) | Return On Assets (0.02) |
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.